Tox21_300583

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

15 Suppliers, 14 USDMF, 1 CEP/COS, 2 EU WC, 6 NDC API, 1 Listed Suppliers

DOSSIERs // Finished Dosage Forms

101 Dossiers, 47 FDA Orange Book, 21 Europe, 21 South Africa, 12 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SOLUTION;ORAL - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 15 Roquette, 13 SPI Pharma, 13 Microlex e.U, 12 Kerry, 9 BASF, 9 Sigachi Industries, 8 Gangwal Healthcare, 4 ACG Worldwide, 4 DFE Pharma, 4 Gangwal Chemicals, 3 Prachin Chemical, 3 Rochem International Inc, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 DKSH, 3 Lonza Capsugel, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Vasa Pharmachem, 2 Pfanstiehl, 2 Actylis, 2 Pharmatrans-Sanaq, 2 Ingredion Pharma Solutions, 1 Nanjing Well Pharmaceutical, 1 Seppic, 1 The Dow Chemical Company, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Finar, 1 Ideal Cures Pvt Ltd, 1 Kima Chemical, 1 Qualicaps

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders, 25 Direct Compression, 18 Thickeners and Stabilizers, 17 Taste Masking, 16 Disintegrants & Superdisintegrants, 14 Granulation, 13 Coating Systems & Additives, 12 Co-Processed Excipients, 12 Lubricants & Glidants, 11 Chewable & Orodispersible Aids, 8 Empty Capsules, 6 Film Formers & Plasticizers, 6 Controlled & Modified Release, 4 Solubilizers, 4 Topical, 4 Parenteral, 3 Rheology Modifiers, 1 API Stability Enhancers, 1 Emulsifying Agents

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 12 Finished Drug Prices

MARKET PLACE

1 APIs

1 APIs

PATENTS

9 Health Canada Patents

9 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 3 EDQM Standards, 2 USP Standards, 2 Other Ref. Standards

DIGITAL CONTENT

3 News

3 News

List of USP reference standards related to Tox21_300583

Tox21_300583

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

15 Suppliers

14 USDMF

1 CEP/COS

2 EU WC

6 NDC API

1 Listed Suppliers

DOSSIERs // Finished Dosage Forms

101 Dossiers

47 FDA Orange Book

21 Europe

21 South Africa

12 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SOLUTION;ORAL - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

15 Roquette

13 SPI Pharma

13 Microlex e.U

12 Kerry

9 BASF

9 Sigachi Industries

8 Gangwal Healthcare

4 ACG Worldwide

4 DFE Pharma

4 Gangwal Chemicals

3 Prachin Chemical

3 Rochem International Inc

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 DKSH

3 Lonza Capsugel

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Vasa Pharmachem

2 Pfanstiehl

2 Actylis

2 Pharmatrans-Sanaq

2 Ingredion Pharma Solutions

1 Nanjing Well Pharmaceutical

1 Seppic

1 The Dow Chemical Company

1 Shijiazhuang Huaxu Pharmaceutical

1 Finar

1 Ideal Cures Pvt Ltd

1 Kima Chemical

1 Qualicaps

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders

25 Direct Compression

18 Thickeners and Stabilizers

17 Taste Masking

16 Disintegrants & Superdisintegrants

14 Granulation

13 Coating Systems & Additives

12 Co-Processed Excipients

12 Lubricants & Glidants

11 Chewable & Orodispersible Aids

8 Empty Capsules

6 Film Formers & Plasticizers

6 Controlled & Modified Release

4 Solubilizers

4 Topical

4 Parenteral

3 Rheology Modifiers

1 API Stability Enhancers

1 Emulsifying Agents

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions

12 Finished Drug Prices

MARKET PLACE

1 APIs

PATENTS

CAPSULE;ORAL - 15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

FOR SOLUTION;ORAL - 1MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons